A significant brain imaging study yields three critical insights that patients and clinicians should understand about long COVID’s neurological basis. First, widespread brain inflammation does not appear to be the primary driver of persistent neurological symptoms—contradicting assumptions that have guided recent research and treatment development. This finding suggests previous anti-inflammatory approaches may require reassessment.
Second, severe long COVID symptoms correlate strongly with heightened activity in emotional processing brain regions, indicating that mood and emotional regulation mechanisms play a central role. Third, this evidence points toward mood-targeted therapeutic interventions—potentially including psychiatric medications, cognitive-behavioral approaches, or mood-regulating therapies—as potentially more effective than inflammation-focused treatments.
For patients managing long COVID symptoms, this research suggests exploring comprehensive approaches that address emotional and mood components alongside physical rehabilitation.
Read the full article on GMJ Newsroom.
Was this article helpful?
